241 related articles for article (PubMed ID: 32080807)
21. A novel VHH antibody targeting the B cell-activating factor for B-cell lymphoma.
Wu W; Li S; Zhang W; Sun J; Ren G; Dong Q
Int J Mol Sci; 2014 May; 15(6):9481-96. PubMed ID: 24879522
[TBL] [Abstract][Full Text] [Related]
22. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
[TBL] [Abstract][Full Text] [Related]
24. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
25. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor.
Qiu L; Feng Y; Ma X; Li J
Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):513-519. PubMed ID: 28475681
[TBL] [Abstract][Full Text] [Related]
26. [Construction and identification of nanobody phage display library targeting Middle East respiratory syndrome coronavirus].
He L; Li J; Ren S; Sun S; Guo Y; Qiu H; Liao Y; Ji K; Fan R; Zhao G; Zhou Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1662-1668. PubMed ID: 29382428
[TBL] [Abstract][Full Text] [Related]
27. Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications.
Yan J; Li G; Hu Y; Ou W; Wan Y
J Transl Med; 2014 Dec; 12():343. PubMed ID: 25496223
[TBL] [Abstract][Full Text] [Related]
28. Selection of similar single domain antibodies from two immune VHH libraries obtained from two alpacas by using different selection methods.
Li T; Vandesquille M; Bay S; Dhenain M; Delatour B; Lafaye P
Immunol Lett; 2017 Aug; 188():89-95. PubMed ID: 28690185
[TBL] [Abstract][Full Text] [Related]
29. Rendomab B4, a monoclonal antibody that discriminates the human endothelin B receptor of melanoma cells and inhibits their migration.
Borrull A; Allard B; Wijkhuisen A; Herbet A; Lamourette P; Birouk W; Leiber D; Tanfin Z; Ducancel F; Boquet D; Couraud JY; Robin P
MAbs; 2016 Oct; 8(7):1371-1385. PubMed ID: 27390909
[TBL] [Abstract][Full Text] [Related]
30. Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools.
Marturano A; Hendrickx MLV; Falcinelli E; Sebastiano M; Guglielmini G; Hassanzadeh-Ghassabeh G; Muyldermans S; Declerck PJ; Gresele P
Nanomedicine; 2020 Feb; 24():102103. PubMed ID: 31669421
[TBL] [Abstract][Full Text] [Related]
31. [Screening, expression and characterization of anti-human CD20 nanobodies].
Li Y; Li G; Wang H; Jiang D; Chu Y; Zhang A; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):67-72. PubMed ID: 33441230
[TBL] [Abstract][Full Text] [Related]
32. Preparation of single chain variable fragment of MG(7) mAb by phage display technology.
Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY
World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR).
Zhu H; Zhao L; Li Z; Wen B; Qiu C; Liu M; Xu Z; Hu S; Li H
Protein Expr Purif; 2019 May; 157():57-62. PubMed ID: 30735705
[TBL] [Abstract][Full Text] [Related]
34. Nanobody against the E7 oncoprotein of human papillomavirus 16.
Li S; Zhang W; Jiang K; Shan H; Shi M; Chen B; Hua Z
Mol Immunol; 2019 May; 109():12-19. PubMed ID: 30849663
[TBL] [Abstract][Full Text] [Related]
35. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
36. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ
MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381
[TBL] [Abstract][Full Text] [Related]
37. Rapid and Sensitive Detection of Staphylococcal Enterotoxin B by Recombinant Nanobody Using Phage Display Technology.
Zanganeh S; Rouhani Nejad H; Mehrabadi JF; Hosseini R; Shahi B; Tavassoli Z; Aramvash A
Appl Biochem Biotechnol; 2019 Feb; 187(2):493-505. PubMed ID: 29984392
[TBL] [Abstract][Full Text] [Related]
38. [Screening and activity analysis of nanobodies against lymphocyte activation gene-3(LAG-3)].
Wen R; Chen Y; Yang Z; Yan F; Li Q; Wu W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Number; 39(11):1024-1031. PubMed ID: 37980554
[TBL] [Abstract][Full Text] [Related]
39. An alpaca single-domain antibody (VHH) phage display library constructed by CDR shuffling provided high-affinity VHHs against desired protein antigens.
Tsukahara N; Murakami A; Motohashi M; Nakayama H; Kondo Y; Ito Y; Azuma T; Kishimoto H
Int Immunol; 2022 Jul; 34(8):421-434. PubMed ID: 35689594
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of a novel nanobody against human placental growth factor to modulate angiogenesis.
Arezumand R; Mahdian R; Zeinali S; Hassanzadeh-Ghassabeh G; Mansouri K; Khanahmad H; Namvar-Asl N; Rahimi H; Behdani M; Cohan RA; Eavazalipour M; Ramazani A; Muyldermans S
Mol Immunol; 2016 Oct; 78():183-192. PubMed ID: 27648860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
